Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Combination pharmaceutical therapies for obesity.

Gadde KM, Allison DB.

Expert Opin Pharmacother. 2009 Apr;10(6):921-5. doi: 10.1517/14656560902824152 .

2.

Combination therapy for obesity and metabolic disease.

Gadde KM, Allison DB.

Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):353-8. doi: 10.1097/MED.0b013e3283304f90. Review.

PMID:
19625958
3.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
4.

Combination treatment to CONQUER obesity?

Shah K, Villareal DT.

Lancet. 2011 Apr 16;377(9774):1295-7. doi: 10.1016/S0140-6736(11)60518-7. No abstract available.

PMID:
21497686
5.

Clinical inquiries: is immediate-release topiramate an effective treatment for adult obesity?

Harshman H, Kovach F.

J Fam Pract. 2014 Dec;63(12):745-6. Review. No abstract available.

PMID:
25486315
6.

Overweight and obesity: pharmacotherapeutic considerations.

Balkon N, Balkon C, Zitkus BS.

J Am Acad Nurse Pract. 2011 Feb;23(2):61-6. doi: 10.1111/j.1745-7599.2010.00587.x. Epub 2011 Jan 11. Review. Erratum in: J Am Acad Nurse Pract. 2011 Jun;23(6):330.

PMID:
21281371
7.

Medications for weight reduction.

Bray GA.

Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009. Review.

PMID:
21855704
8.

Rimonabant, obesity and diabetes.

[No authors listed]

Prescrire Int. 2007 Jun;16(89):122.

PMID:
17585427
9.

Anti-obesity drugs.

Kushner RF.

Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. doi: 10.1517/14656566.9.8.1339 . Review.

PMID:
18473708
10.

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Review.

PMID:
23800750
11.

Weight loss medications--where do they fit in?

Dixon JB.

Aust Fam Physician. 2006 Aug;35(8):576-9. Review.

12.

The incretin pathway as a new therapeutic target for obesity.

Barber TM, Begbie H, Levy J.

Maturitas. 2010 Nov;67(3):197-202. doi: 10.1016/j.maturitas.2010.06.018. Epub 2010 Jul 23. Review.

PMID:
20655673
13.

Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice.

Gadde KM.

Expert Opin Pharmacother. 2014 Apr;15(6):809-22. doi: 10.1517/14656566.2014.890590. Epub 2014 Feb 19. Review.

PMID:
24548209
14.

Pharmacotherapy for childhood obesity: present and future prospects.

Sherafat-Kazemzadeh R, Yanovski SZ, Yanovski JA.

Int J Obes (Lond). 2013 Jan;37(1):1-15. doi: 10.1038/ijo.2012.144. Epub 2012 Aug 28. Review.

15.

Contrave--a combination of bupropion and naltrexone for weight loss.

[No authors listed]

Med Lett Drugs Ther. 2014 Nov 10;56(1455):112-4. No abstract available.

PMID:
25372849
16.

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group.

Lancet. 2010 Aug 21;376(9741):595-605. doi: 10.1016/S0140-6736(10)60888-4. Epub 2010 Jul 29. Erratum in: Lancet. 2010 Aug 21;376(9741):594. Lancet. 2010 Oct 23;376(9750):1392.

PMID:
20673995
17.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

18.

Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone-bupropion combination?

Citrome L.

Int J Clin Pract. 2010 Oct;64(11):1462-1465. doi: 10.1111/j.1742-1241.2010.02501.x. No abstract available.

PMID:
20846190
19.

The future of obesity reduction: beyond weight loss.

Ross R, Bradshaw AJ.

Nat Rev Endocrinol. 2009 Jun;5(6):319-25. doi: 10.1038/nrendo.2009.78. Review.

PMID:
19421242
20.

Combination phentermine and topiramate for weight maintenance: the first Australian experience.

Neoh SL, Sumithran P, Haywood CJ, Houlihan CA, Lee FT, Proietto J.

Med J Aust. 2014 Aug 18;201(4):224-6.

PMID:
25164851

Supplemental Content

Support Center